Journal article
High mucosal cytomegalovirus DNA helps predict adverse short-term outcome in acute severe ulcerative colitis
- Abstract:
- Background/Aims: Predictors of short-term outcome of intravenous (IV) steroid therapy in acute severe ulcerative colitis (ASUC) have been well described, but the impact of cytomegalovirus (CMV) infection as a predictor of outcome remains debatable. We investigated the role of quantitative CMV polymerase chain reaction (PCR) as a predictor of short-term outcome in patients with ASUC.Methods: Consecutive patients with ASUC satisfying Truelove and Witts criteria hospitalized at All India Institute of Medical Sciences (AIIMS) from May 2016 to July 2019 were included; all received IV steroid. The primary outcome measure was steroid-failure defined as the need for rescue therapy (with ciclosporin or infliximab) or colectomy during admission. AIIMS’ index (ulcerative colitis index of severity > 6 at day 1+fecal calprotectin > 1,000 μg/g at day 3), with quantitative CMV PCR on biopsy samples obtained at initial sigmoidoscopy were correlated with the primary outcome.Results: Thirty of 76 patients (39%) failed IV corticosteroids and 12 (16%) underwent surgery. Patients with steroid failure had a significantly higher mucosal CMV DNA than responders (3,454 copies/mg [0–2,700,000] vs. 116 copies/mg [0–27,220]; P< 0.01). On multivariable analysis, mucosal CMV DNA load > 2,000 copies/mg (odds ratio [OR], 10.2; 95% confidence interval [CI], 2.6–39.7; P< 0.01) and AIIMS’ index (OR, 39.8; 95% CI, 4.4–364.4; P< 0.01) were independent predictors of steroid-failure and need for colectomy. The combination correctly predicted outcomes in 84% of patients with ASUC.Conclusions: High mucosal CMV DNA ( > 2,000 copies/mg) independently predicts failure of IV corticosteroids and short-term risk of colectomy and it has an additional value to the established markers of disease severity in patients with ASUC.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 367.5KB, Terms of use)
-
- Publisher copy:
- 10.5217/ir.2020.00055
Authors
+ National Institute for Health Research
More from this funder
- Funder identifier:
- 10.13039/501100000272
+ NIHR Oxford Biomedical Research Centre
More from this funder
- Funder identifier:
- 10.13039/501100013373
- Publisher:
- Korean Association for the Study of Intestinal Diseases
- Journal:
- Intestinal Research More from this journal
- Volume:
- 19
- Issue:
- 4
- Pages:
- 438-447
- Publication date:
- 2020-11-05
- DOI:
- EISSN:
-
2288-1956
- ISSN:
-
1598-9100
- Language:
-
English
- Keywords:
- Pubs id:
-
1141215
- Local pid:
-
pubs:1141215
- Source identifiers:
-
W3095269147
- Deposit date:
-
2026-02-12
- ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.
Terms of use
- Copyright date:
- 2020
If you are the owner of this record, you can report an update to it here: Report update to this record